ES2192219T3 - Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto. - Google Patents

Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto.

Info

Publication number
ES2192219T3
ES2192219T3 ES96308853T ES96308853T ES2192219T3 ES 2192219 T3 ES2192219 T3 ES 2192219T3 ES 96308853 T ES96308853 T ES 96308853T ES 96308853 T ES96308853 T ES 96308853T ES 2192219 T3 ES2192219 T3 ES 2192219T3
Authority
ES
Spain
Prior art keywords
prevention
treatment
bismute
compositions
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96308853T
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of ES2192219T3 publication Critical patent/ES2192219T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION INCLUYE METODOS PARA LA PREVENCION Y TRATAMIENTO DE UN SER HUMANO O ANIMAL INFERIOR QUE TENGA UNA ENFERMEDAD UROGENITAL CAUSADA O INFLUIDA POR UNO O MAS PROTOZOOS PARASITOS Y QUE SUPONE LA ADMINISTRACION DE BISMUTO AL SUJETO.
ES96308853T 1995-12-07 1996-12-05 Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto. Expired - Lifetime ES2192219T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56885295A 1995-12-07 1995-12-07

Publications (1)

Publication Number Publication Date
ES2192219T3 true ES2192219T3 (es) 2003-10-01

Family

ID=24273004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96308853T Expired - Lifetime ES2192219T3 (es) 1995-12-07 1996-12-05 Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto.

Country Status (8)

Country Link
US (1) US5882686A (es)
EP (1) EP0776665B1 (es)
AT (1) ATE232736T1 (es)
DE (1) DE69626260T2 (es)
DK (1) DK0776665T3 (es)
ES (1) ES2192219T3 (es)
NO (1) NO314979B1 (es)
PT (1) PT776665E (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767699A1 (fr) 1997-08-28 1999-02-26 Oreal Composition filmogene epaissie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (es) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
US5882686A (en) 1999-03-16
DE69626260D1 (de) 2003-03-27
NO965191L (no) 1997-06-09
PT776665E (pt) 2003-06-30
DK0776665T3 (da) 2003-03-31
NO965191D0 (no) 1996-12-05
EP0776665B1 (en) 2003-02-19
NO314979B1 (no) 2003-06-23
EP0776665A1 (en) 1997-06-04
DE69626260T2 (de) 2003-12-04
ATE232736T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
EP0686629A3 (en) Cyclohexyl tachykinine receptor antagonists
BR1100384A (pt) Composto e formulação farmacêutica
ES2192219T3 (es) Composiciones para la prevencion y tratamiento de trastornos urogenitales, que contienen bismuto.
DK0778028T3 (da) Præparater til forebyggelse og behandling af urogenitale lidelser, der indeholder bismuth og ét eller flere antimikrobielle midler
ES2173334T3 (es) Composiciones que contienen bismuto, para la prevencion y tratamiento de trastornos gastrointestinales.
ES2191776T3 (es) Composiciones que contienen bismuto y uno o mas agentes antimicrobianos, para la prevencion y tratamiento de trastornos gastrointestinales.
PE37498A1 (es) Composiciones para la prevencion y tratamiento de trastornos gastrointestinales
BR9611913A (pt) Composições contendo bismuto para a prevenção e tratamento de distúrbios gastrintestinais